Table 2.
Characteristics of 31 solid renal lesions in terms of sestamibi uptake
| Type of lesions | Number of lesions | sestamibi positive | sestamibi negative |
|---|---|---|---|
| Oncocytoma | 12 (39%) | 11 (91.6%) | 1 (8.4%) |
| Hybrid (oncocytoma-chromophobe RCC) | 3 (10%) | 3 (100%) | 0 |
| Metanephric adenoma | 1 (3%) | 0 | 1 (100%) |
| Lymphoma | 1 (3%) | 0 | 1 (100%) |
| Angiomyolipoma | 1 (3%) | 1 (100%) | 0 |
| Clear cell RCC | 7 (23%) | 0 | 7 (100%) |
| Papillary RCC | 3 (10%) | 1 (33.3%) | 2 (66.7%) |
| Chromophobe RCC | 2 (6%) | 0 | 2 (100%) |
| Collision (chromophobe-papillary RCC) | 1 (3%) | 0 | 1 (100%) |
RCC renal cell carcinoma